Percutaneous transluminal angioplasty of dysfunctional hemodialysis vascular access: Can careful selection of patients improve the outcomes?-Reference-Cited by-同舟云学术

Percutaneous transluminal angioplasty of dysfunctional hemodialysis vascular access: Can careful selection of patients improve the outcomes?

Published:2022 Issue:3 Volume:32 Page:233
ISSN:0971-4065
Container-title:Indian Journal of Nephrology
language:en
Short-container-title:Indian J Nephrol

Author:

Shah OmairA,Khan Tahir,Bhat Mudasir,Choh NaseerA,Maqsood Shadab,Shera TahleelA

Publisher

Medknow

Subject

Nephrology

Reference28 articles.

1. Chronic kidney disease and its complications?;Thomas;Prim Care,2008

2. A review of percutaneous transluminal angioplasty in hemodialysis fistula;Bountouris;Int J Vasc Med,2018

3. Assessment of self-reported prognostic expectations of people undergoing dialysis: United States renal data system study of treatment preferences (USTATE);O'Hare;JAMA Intern Med,2019

4. Functional durability of hemodialysis access;Rockley;J Vasc Surg,2019

5. Recommended standards for reports dealing with arteriovenous hemodialysis accesses;Sidawy;J VascSurg,2002

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Артеріовенозна фістула для гемодіалізу: сучасні рекомендації та стратегії догляду;Ukrainian Journal of Nephrology and Dialysis;2023-11-17

2. Outflow Rescue of Elbow-Blockade Forearm Arteriovenous Fistulas: Outcomes of Open Surgical Techniques;Annals of Vascular Surgery;2023-08

3. Comparison of drug‐coated balloon angioplasty versus common balloon angioplasty for arteriovenous fistula stenosis: A systematic review and meta‐analysis;Clinical Cardiology;2023-07-07

4. Comparison of drug-coated balloon angioplasty versus common balloon angioplasty in hemodialysis patients with arteriovenous fistula stenosis: A meta-analysis of randomised controlled trials;2023-01-11

5. Early inadequate venous flow volume after technically successful balloon angioplasty of radiocephalic arteriovenous fistula: causes and follow-up results;EUR REV MED PHARMACO;2023